Home › Funds › JOHNSON & JOHNSON › VOR

JOHNSON & JOHNSON position in VOR

VOR BIOPHARMA INC · Health Care

JOHNSON & JOHNSON reported holding 53,732 shares of VOR (VOR BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$1.0M, representing 0.13% of its reported portfolio and ranking #13 among its reported holdings. JOHNSON & JOHNSON has disclosed VOR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)53.73K sh
Reported value held$1.03M
Portfolio Weight0.13%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How JOHNSON & JOHNSON's VOR position evolved

JOHNSON & JOHNSON first disclosed a stake in VOR in Q3 2023 at 1,074,658 shares (US$2.3M). The position peaked in Q3 2025 at 53,732 shares, worth US$2.6M. Across 13 filings, JOHNSON & JOHNSON increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 53,732 shares valued at US$1.0M. Notable position changes include a 95% trim in Q3 2025 (shares fell 73% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.07M $2.28M New
Q4 2023 1.07M $2.42M Hold
Q1 2024 1.07M $2.55M Hold
Q2 2024 1.07M $1.07M Hold
Q3 2024 1.07M $752.26K Hold
Q4 2024 1.07M $1.19M Hold
Q1 2025 1.07M $771.07K Hold
Q2 2025 1.07M $1.14M Hold
Q3 2025 53.73K $2.62M Reduce
Q4 2025 53.73K $702.82K Hold
Q1 2026 53.73K $958.58K Hold
Q2 2026 53.73K $989.21K Hold
Q3 2026 53.73K $1.03M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VOR and 13F data

VOR (VOR BIOPHARMA INC) is a Health Care company. 75 other funds we track also report a position in VOR — the largest reported positions include TCG Crossover Management, LLC (US$104.4M), FCPM III SERVICES B.V. (US$75.8M), Venrock Adviser, LLC (US$56.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VOR

All VOR fund holders →

FAQ

How long has JOHNSON & JOHNSON held VOR?

JOHNSON & JOHNSON has disclosed VOR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is JOHNSON & JOHNSON's current position in VOR?

As of Q3 2026, JOHNSON & JOHNSON holds 53.73K shares of VOR (VOR BIOPHARMA INC), valued at $1.03M, representing 0.13% of its reported portfolio and ranking #13.

Has JOHNSON & JOHNSON been buying or selling VOR?

In the latest 13F filing (Q3 2026), JOHNSON & JOHNSON held unchanged its position in VOR. The position peaked in Q3 2025 at 53.73K shares.

Which other funds hold VOR?

Other major institutional holders of VOR include TCG Crossover Management, LLC, FCPM III SERVICES B.V., Venrock Adviser, LLC, among 75 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.